Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Genmab A/S
  6. News
  7. Summary
    GMAB   DK0010272202

GENMAB A/S

(GMAB)
  Report
Real-time Estimate Cboe Europe  -  05:08 2022-09-30 am EDT
2432.50 DKK   +0.19%
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for TIVDAK (tisotumab vedotin-tftv)
AQ
09/28Genmab A/s : has published its Articles of Association
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about GENMAB A/S
09/28Genmab A/s : has published its Articles of Association
PU
09/27Capital Increase in Genmab as a Result of Employee Warrant Exercise
GL
09/26Genmab A/s : Articles of Association - September 20, 2022 (English)
PU
09/26Genmab A/s : has published its Articles of Association
PU
09/20Grant of Restricted Stock Units and Warrants to Employees in Genmab
GL
09/20Grant of Restricted Stock Units and Warrants to Employees in Genmab
GL
09/15Credit Suisse Raises Price Target on Genmab to DKK2,800 From DKK2,600, Citing Higher Da..
MT
09/13Transcript : Genmab A/S Presents at Morgan Stanley 20th Annual Global Healthc..
CI
09/06Genmab to Present at Morgan Stanley 20th Annual Global Healthcare Conference
GL
09/02Genmab A/S - Completion of share buy-back program
AQ
09/01Danish Biotech Group Genmab Concludes $122 Million Share Buyback Program
MT
09/01Completion of share buy-back program
GL
09/01Completion of share buy-back program
GL
09/01Tranche Update on Genmab A/S's Equity Buyback Plan announced on March 1, 2021.
CI
08/30Genmab A/S - Transactions in connection with share buy-back program
AQ
More most relevant news
All news about GENMAB A/S
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Genmab A/s : has published its Articles of Association
PU
09/27Capital Increase in Genmab as a Result of Employee Warrant Exercise
GL
09/27Zai Lab Signs Exclusive Collaboration, License Agreement With Seagen to Develop, Commer..
MT
09/26Genmab A/s : Articles of Association - September 20, 2022 (English)
PU
09/26Genmab A/s : has published its Articles of Association
PU
09/20Grant of Restricted Stock Units and Warrants to Employees in Genmab
GL
09/20Grant of Restricted Stock Units and Warrants to Employees in Genmab
GL
09/15Credit Suisse Raises Price Target on Genmab to DKK2,800 From DKK2,600, Citing Higher Da..
MT
More news
News in other languages on GENMAB A/S
09/27Zai Lab signe un accord exclusif de collaboration et de licence avec Seagen pour dévelo..
09/01Le groupe biotechnologique danois Genmab conclut un programme de rachat d'actions de 12..
08/10Genmab A/S annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 j..
08/10Genmab confirme ses prévisions révisées à la hausse pour l'exercice 22, en raison de l'..
08/10L'inflation à quitte ou double
08/10EN DIRECT DES MARCHES : EDF, Eutelsat, Ahold Delhaize, Sika, Coinb..
08/10Avis d'analystes du jour : Aperam, Evotec, Hugo Boss, Lonza, Pr..
08/08Genmab revoit à la hausse ses perspectives pour l'exercice 22 en raison de l'augmentati..
08/08Genmab revoit à la hausse ses prévisions de revenus pour 2022 ; les actions chutent dan..
08/08Genmab A/S révise ses prévisions de bénéfices pour l'année 2022
More news
Analyst Recommendations on GENMAB A/S
09/15Credit Suisse Raises Price Target on Genmab to DKK2,800 From DKK2,600, Citing Higher Da..
MT
08/22HC Wainwright Adjusts Price Target on Genmab A/S to $51 from $49, Reiterates Buy Rating
MT
08/15Morgan Stanley Adjusts Price Target on Genmab A/S to $31 From $29, Maintains Underweigh..
MT
08/05RBC Cuts Price Target on Genmab to DKK3,139 From DKK3,340, Maintains Outperform Rating
MT
07/20HC Wainwright Adjusts Price Target on Genmab A/S to $49 From $47, Reiterates Buy Rating
MT
More recommendations
Press releases
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Genmab A/s : has published its Articles of Association
PU
09/27Capital Increase in Genmab as a Result of Employee Warrant Exercise
GL
09/26Genmab A/s : Articles of Association - September 20, 2022 (English)
PU
More press releases